Uncovering LINC02982: a T-ALL-specific lncrna linking epigenetic regulation and metabolic pathways
- 1IRCCS SYNLAB SDN, Via G. Ferraris 144, Naples, 80146 Italy
- 2Department of Pediatric Hemato-Oncology, Santobono-Pausilipon Children’s Hospital, AORN, Naples, 80122 Italy
Abstract
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive pediatric malignancy with limited molecular biomarkers to guide diagnosis and personalized therapy. Given the critical role of long non-coding RNAs in gene regulation and chromatin dynamics, we investigated whether novel lncRNAs could contribute to T-ALL pathogenesis. Through transcriptomic profiling of patient samples and in-silico validation on public datasets, we identified LINC02982 as a lncRNA selectively overexpressed in T-ALL and specifically enriched in leukemic blasts. Functional silencing of LINC02982 in multiple T-ALL cell lines impaired proliferation, altered cell-cycle progression, and increased apoptosis. Integrative ATAC-seq and RNA-seq analyses revealed widespread changes in chromatin accessibility and gene expression, including deregulation of metabolic genes such as AK4 and PSAT1. Promoter accessibility showed a moderate correlation with transcriptional changes, consistent with a potential cis-regulatory role, while broader transcriptomic alterations suggest additional trans effects. Pathway analysis highlighted metabolic processes, including cholesterol biosynthesis, as significantly affected, with LINC02982 depletion reducing expression of key pathway genes and intracellular cholesterol levels. These findings identify LINC02982 as a T-ALL–associated lncRNA linked to transcriptional and metabolic alterations, supporting its potential biological relevance in leukemic cellular regulation and warranting further investigation in larger clinical cohorts.
Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s12935-026-04433-w.
Related
- Lactylation in cancer: a new frontier in metabolic-epigenetic regulation and clinical practice.
- CAST as a Tumor-Specific Suppressor in Colorectal Cancer: Discovery Through Integrative Analysis of Unannotated Isoforms, Proteomics, and Epigenetic Regulation
- Metabolic-epigenetic regulation of the HBV cccDNA reservoir: pathways underpinning viral persistence
- Bromodomain and extra-terminal motif (BET) inhibition induces coordinated repression of the stem cell-related HOX signature in glioblastoma uncovering an epigenetic vulnerability
- Uncovering KRAS-mutant allele-specific biology and vulnerabilities in non-small cell lung cancer
BibTeX
@article{pecoraro2026uncovering,
title = {{Uncovering LINC02982: a T-ALL-specific lncrna linking epigenetic regulation and metabolic pathways}},
author = {Giovanni Pecoraro and Katia Pane and Monica Franzese and Giuliana Beneduce and Antonia De Matteo and Rosanna Parasole and Giovanni Smaldone},
journal = {Cancer Cell International},
year = {2026},
month = jul,
doi = {10.1186/s12935-026-04433-w},
url = {https://doi.org/10.1186/s12935-026-04433-w},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Uncovering LINC02982: a T-ALL-specific lncrna linking epigenetic regulation and metabolic pathways
AU - Giovanni Pecoraro
AU - Katia Pane
AU - Monica Franzese
AU - Giuliana Beneduce
AU - Antonia De Matteo
AU - Rosanna Parasole
AU - Giovanni Smaldone
PY - 2026
DA - 2026/07/31
JO - Cancer Cell International
DO - 10.1186/s12935-026-04433-w
UR - https://doi.org/10.1186/s12935-026-04433-w
AB - T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive pediatric malignancy with limited molecular biomarkers to guide diagnosis and personalized therapy. Given the critical role of long non-coding RNAs in gene regulation and chromatin dynamics, we investigated whether novel lncRNAs could contribute to T-ALL pathogenesis. Through transcriptomic profiling of patient samples and in-silico validation on public datasets, we identified LINC02982 as a lncRNA selectively overexpressed in T-ALL and specifically enriched in leukemic blasts. Functional silencing of LINC02982 in multiple T-ALL cell lines impaired proliferation, altered cell-cycle progression, and increased apoptosis. Integrative ATAC-seq and RNA-seq analyses revealed widespread changes in chromatin accessibility and gene expression, including deregulation of metabolic genes such as AK4 and PSAT1. Promoter accessibility showed a moderate correlation with transcriptional changes, consistent with a potential cis-regulatory role, while broader transcriptomic alterations suggest additional trans effects. Pathway analysis highlighted metabolic processes, including cholesterol biosynthesis, as significantly affected, with LINC02982 depletion reducing expression of key pathway genes and intracellular cholesterol levels. These findings identify LINC02982 as a T-ALL–associated lncRNA linked to transcriptional and metabolic alterations, supporting its potential biological relevance in leukemic cellular regulation and warranting further investigation in larger clinical cohorts. Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s12935-026-04433-w.
SN - 1475-2867
ER -